US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ovid Therapeutics Inc.

1.79

+0.320021.77%

Volume:4.81M

Turnover:8.27M

Market Cap:127.47M

PE:-3.55

High:1.79

Open:1.56

Low:1.55

Close:1.47

52wk High:2.01

52wk Low:0.2425

Shares:71.21M

Float Shares:59.52M

Volume Ratio:3.24

T/O Rate:8.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5047

EPS(LYR):-0.3663

ROE:-60.06%

ROA:-29.33%

PB:2.85

PE(LYR):-4.89

Loading ...

Overview Company News Filings

Ra Capital Management, L.p. Reports 9.9% Passive Stake in Ovid Therapeutics as of Dec 11 - SEC Filing

THOMSON REUTERS

BRIEF-Ovid Therapeutics Announces Phase 1 Results For Ov350

Ovid Therapeutics Showcases Neurotherapeutics Pipeline Targeting Neural Hyperexcitability

Ovid Therapeutics Inc - Ov350 Shows Good Safety Profile Supporting Kcc2 Portfolio Advancement

THOMSON REUTERS

Ovid Therapeutics Inc - Announces Phase 1 Results for Ov350

THOMSON REUTERS

Ovid Therapeutics Inc - No Treatment-Related Safety Findings or Serious Adverse Events

THOMSON REUTERS

Ovid Therapeutics Announces Phase 1/1b Clinical Trial Submission for Oral KCC2 Activator OV4071

Ovid Therapeutics Inc. Held Special Shareholder Meeting

Ovid Therapeutics Names Dr. Petra Kaufmann as Chief Medical Officer

Ovid Therapeutics Appoints DR. Petra Kaufmann as Chief Medical Officer

THOMSON REUTERS

Ovid Therapeutics Showcases Neurotherapeutics Pipeline Targeting Drug-Resistant Seizures and Neural Hyperexcitability

BTIG Keeps Their Buy Rating on Ovid Therapeutics (OVID)

Ovid Therapeutics Q3 revenue slightly beats expectations

Ovid Therapeutics reports Q3 revenue of $132,000 and R&D expenses of $5.9 million

BRIEF-Ovid Therapeutics Q3 EPS USD -0.17

Ovid Therapeutics Names Meg Alexander as CEO

Ovid Therapeutics Q3 Revenue USD 132 Thousand VS. Ibes Estimate USD 153.3 Thousand

THOMSON REUTERS

Ovid Therapeutics Inc - Jeremy M. Levin to Transition to Executive Chair of Bod

THOMSON REUTERS

Ovid Therapeutics Inc - Meg Alexander Appointed CEO Effective January 1, 2026

THOMSON REUTERS

Press Release: Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OVID/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OVID","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OVID\",,,,,undefined,":{"symbol":"OVID","market":"US","secType":"STK","nameCN":"Ovid Therapeutics Inc.","latestPrice":1.79,"timestamp":1766437200000,"preClose":1.47,"halted":0,"volume":4809206,"delay":0,"floatShares":59524501,"shares":71212400,"eps":-0.504739,"marketStatus":"Pre-Mkt","change":0.32,"latestTime":"12-23 05:53:05 EST","open":1.56,"high":1.79,"low":1.55,"amount":8271549.6150048,"amplitude":0.163265,"askPrice":1.8,"askSize":10,"bidPrice":1.77,"bidSize":150,"shortable":3,"etf":0,"ttmEps":-0.504739,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766500200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1493956800000,"exchange":"NASDAQ","adjPreClose":1.79,"postHourTrading":{"tag":"盘后","latestPrice":1.7502,"preClose":1.79,"latestTime":"19:59 EST","volume":59374,"amount":105381.5792,"timestamp":1766451595077},"volumeRatio":3.2424606750590113,"impliedVol":1.0752,"impliedVolPercentile":0.6185},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OVID\",,,,,undefined,":{"symbol":"OVID","floatShares":59524501,"roa":"-29.33%","roe":"-60.06%","lyrEps":-0.366333,"volumeRatio":3.2424606750590113,"shares":71212400,"dividePrice":0,"high":1.79,"amplitude":0.163265,"preClose":1.47,"low":1.55,"week52Low":0.2425,"pbRate":"2.85","psRate":"19.28","week52High":2.01,"institutionHeld":0,"latestPrice":1.79,"committee":0.875,"eps":-0.504739,"divideRate":0,"volume":4809206,"delay":0,"ttmEps":-0.504739,"open":1.56,"prevYearClose":0.9337,"prevWeekClose":1.47,"prevMonthClose":1.78,"prevQuarterClose":1.3,"fiveDayClose":1.56,"twentyDayClose":1.4,"sixtyDayClose":1.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OVID\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"OVID","fiscalQuarterEnding":"2025/09","expectedEps":-0.15,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2025-08-13","symbol":"OVID","fiscalQuarterEnding":"2025/06","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2025-05-13","symbol":"OVID","fiscalQuarterEnding":"2025/03","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.14},{"market":"US","date":"2025-03-11","symbol":"OVID","fiscalQuarterEnding":"2024/12","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2024-11-12","symbol":"OVID","fiscalQuarterEnding":"2024/09","expectedEps":-0.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OVID\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OVID\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":10,"updateTime":1765688400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OVID\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OVID","date":"2025-12-19","current":-3.546387,"percent":0.380991,"low":-5.884982,"twenty":-4.218628,"median":-2.236091,"eighty":1.513783,"high":2.64739,"avg":-1.922817,"sd":2.318832,"marketCap":95424553},"quantilePoints":[{"date":"2020-12-24","current":-2.179208,"twenty":-6.025029,"median":-3.374349,"eighty":-1.744811,"marketCap":165565929},{"date":"2020-12-31","current":-1.928724,"twenty":-6.009068,"median":-3.365908,"eighty":-1.746791,"marketCap":146535362},{"date":"2021-01-08","current":-2.020568,"twenty":-6.000093,"median":-3.357802,"eighty":-1.747734,"marketCap":153513237},{"date":"2021-01-15","current":-2.062315,"twenty":-5.989063,"median":-3.341501,"eighty":-1.760204,"marketCap":156684998},{"date":"2021-01-22","current":-2.262702,"twenty":-5.96874,"median":-3.339166,"eighty":-1.794986,"marketCap":171909451},{"date":"2021-01-29","current":-2.346197,"twenty":-5.96874,"median":-3.33263,"eighty":-1.812846,"marketCap":178252973},{"date":"2021-02-05","current":-2.663476,"twenty":-5.954658,"median":-3.320514,"eighty":-1.815132,"marketCap":202358358},{"date":"2021-02-12","current":-2.855514,"twenty":-5.92671,"median":-3.314518,"eighty":-1.818921,"marketCap":216948459},{"date":"2021-02-19","current":-2.897261,"twenty":-5.920925,"median":-3.306927,"eighty":-1.825804,"marketCap":220120220},{"date":"2021-02-26","current":-2.463089,"twenty":-5.912911,"median":-3.291691,"eighty":-1.835035,"marketCap":187133904},{"date":"2021-03-05","current":-3.314734,"twenty":-5.904701,"median":-3.293414,"eighty":-1.850453,"marketCap":251837831},{"date":"2021-03-12","current":-3.423277,"twenty":-5.903059,"median":-3.309703,"eighty":-1.856274,"marketCap":260084410},{"date":"2021-03-19","current":-3.62703,"twenty":-5.890307,"median":-3.314734,"eighty":-1.868955,"marketCap":293918457},{"date":"2021-03-26","current":-3.221322,"twenty":-5.873599,"median":-3.313499,"eighty":-1.881006,"marketCap":261041672},{"date":"2021-04-01","current":-3.302463,"twenty":-5.860098,"median":-3.308752,"eighty":-1.887678,"marketCap":267617029},{"date":"2021-04-09","current":-2.994125,"twenty":-5.828989,"median":-3.296406,"eighty":-1.898454,"marketCap":242630673},{"date":"2021-04-16","current":-3.067153,"twenty":-5.807822,"median":-3.281489,"eighty":-1.904671,"marketCap":248548494},{"date":"2021-04-23","current":-2.977897,"twenty":-5.793302,"median":-3.267519,"eighty":-1.907715,"marketCap":241315601},{"date":"2021-04-30","current":-3.07009,"twenty":-5.782269,"median":-3.26453,"eighty":-1.916612,"marketCap":248786532},{"date":"2021-05-07","current":-2.911148,"twenty":-5.760203,"median":-3.247572,"eighty":-1.925829,"marketCap":235906576},{"date":"2021-05-14","current":2.110836,"twenty":-5.740215,"median":-3.238321,"eighty":-1.916612,"marketCap":242750012},{"date":"2021-05-21","current":2.323099,"twenty":-5.731976,"median":-3.234778,"eighty":-1.887678,"marketCap":267160628},{"date":"2021-05-28","current":2.446919,"twenty":-5.728704,"median":-3.221322,"eighty":-1.847068,"marketCap":281400153},{"date":"2021-06-04","current":2.582531,"twenty":-5.721303,"median":-3.214475,"eighty":-1.816648,"marketCap":296995825},{"date":"2021-06-11","current":2.64739,"twenty":-5.709423,"median":-3.213654,"eighty":-1.748678,"marketCap":304454624},{"date":"2021-06-18","current":2.576635,"twenty":-5.704765,"median":-3.204568,"eighty":-1.730112,"marketCap":296317752},{"date":"2021-06-25","current":2.558947,"twenty":-5.696672,"median":-3.191201,"eighty":-1.701961,"marketCap":294283534},{"date":"2021-07-02","current":2.382061,"twenty":-5.682542,"median":-3.187953,"eighty":-1.689922,"marketCap":273941354},{"date":"2021-07-09","current":2.323099,"twenty":-5.667276,"median":-3.178011,"eighty":-1.662002,"marketCap":267160628},{"date":"2021-07-16","current":2.181591,"twenty":-5.64362,"median":-3.166735,"eighty":-1.631785,"marketCap":250886884},{"date":"2021-07-23","current":2.205175,"twenty":-5.623035,"median":-3.163317,"eighty":-1.60715,"marketCap":253599174},{"date":"2021-07-30","current":2.199279,"twenty":-5.619001,"median":-3.156126,"eighty":-1.592728,"marketCap":252921102},{"date":"2021-08-06","current":2.199279,"twenty":-5.613587,"median":-3.15256,"eighty":-1.57688,"marketCap":252921102},{"date":"2021-08-13","current":2.382061,"twenty":-5.598279,"median":-3.145171,"eighty":-1.571677,"marketCap":273941354},{"date":"2021-08-20","current":1.958215,"twenty":-5.585146,"median":-3.140061,"eighty":-1.55297,"marketCap":238441305},{"date":"2021-08-27","current":1.963794,"twenty":-5.561431,"median":-3.131046,"eighty":-1.529528,"marketCap":239120625},{"date":"2021-09-03","current":1.958215,"twenty":-5.560792,"median":-3.126778,"eighty":-1.522882,"marketCap":238441305},{"date":"2021-09-10","current":1.924742,"twenty":-5.558235,"median":-3.122117,"eighty":-1.512554,"marketCap":234365386},{"date":"2021-09-17","current":1.88011,"twenty":-5.555054,"median":-3.118746,"eighty":-1.497774,"marketCap":228930826},{"date":"2021-09-24","current":1.924742,"twenty":-5.552388,"median":-3.114765,"eighty":-1.482993,"marketCap":234365386},{"date":"2021-10-01","current":1.969373,"twenty":-5.50324,"median":-3.108386,"eighty":-1.47217,"marketCap":239799945},{"date":"2021-10-08","current":2.014005,"twenty":-5.498772,"median":-3.105551,"eighty":-1.460552,"marketCap":245234505},{"date":"2021-10-15","current":2.008426,"twenty":-5.492554,"median":-3.097778,"eighty":-1.451557,"marketCap":244555185},{"date":"2021-10-22","current":2.002847,"twenty":-5.448118,"median":-3.094944,"eighty":-1.443578,"marketCap":243875865},{"date":"2021-10-29","current":1.896847,"twenty":-5.435084,"median":-3.088116,"eighty":-1.43667,"marketCap":230968786},{"date":"2021-11-05","current":2.002847,"twenty":-5.419977,"median":-3.083468,"eighty":-1.427559,"marketCap":243875865},{"date":"2021-11-12","current":1.911659,"twenty":-5.419977,"median":-3.076601,"eighty":-1.419804,"marketCap":242408178},{"date":"2021-11-19","current":1.847221,"twenty":-5.418663,"median":-3.073262,"eighty":-1.405253,"marketCap":234237116},{"date":"2021-11-26","current":1.750564,"twenty":-5.388196,"median":-3.069798,"eighty":-1.401836,"marketCap":221980523},{"date":"2021-12-03","current":1.723715,"twenty":-5.362569,"median":-3.067153,"eighty":-1.393524,"marketCap":218575913},{"date":"2021-12-10","current":1.750564,"twenty":-5.351432,"median":-3.048771,"eighty":-1.383007,"marketCap":221980523},{"date":"2021-12-17","current":1.745194,"twenty":-5.332888,"median":-3.040405,"eighty":-1.379278,"marketCap":221299601},{"date":"2021-12-23","current":1.820372,"twenty":-5.308774,"median":-3.034696,"eighty":-1.370718,"marketCap":230832507},{"date":"2021-12-31","current":1.723715,"twenty":-5.292522,"median":-3.023615,"eighty":-1.360829,"marketCap":218575913},{"date":"2022-01-07","current":1.831189,"twenty":-5.27874,"median":-3.012907,"eighty":-1.353596,"marketCap":232204209},{"date":"2022-01-14","current":1.736855,"twenty":-5.268144,"median":-3.007108,"eighty":-1.344586,"marketCap":220242174},{"date":"2022-01-21","current":1.720208,"twenty":-5.263736,"median":-3.004051,"eighty":-1.338336,"marketCap":218131227},{"date":"2022-01-28","current":1.492697,"twenty":-5.25862,"median":-3.00224,"eighty":-1.331151,"marketCap":189281613},{"date":"2022-02-04","current":1.548187,"twenty":-5.254778,"median":-2.994125,"eighty":-1.318059,"marketCap":196318104},{"date":"2022-02-11","current":1.747953,"twenty":-5.229023,"median":-2.978193,"eighty":-1.309895,"marketCap":221649472},{"date":"2022-02-18","current":1.786797,"twenty":-5.192421,"median":-2.970472,"eighty":-1.305625,"marketCap":226575016},{"date":"2022-02-25","current":1.814542,"twenty":-5.187662,"median":-2.969783,"eighty":-1.299407,"marketCap":230093262},{"date":"2022-03-04","current":1.847837,"twenty":-5.17238,"median":-2.960868,"eighty":-1.292345,"marketCap":234315156},{"date":"2022-03-11","current":1.875582,"twenty":-5.128635,"median":-2.946729,"eighty":-1.281502,"marketCap":237833402},{"date":"2022-03-18","current":1.839041,"twenty":-5.12542,"median":-2.933837,"eighty":-1.267503,"marketCap":225897850},{"date":"2022-03-25","current":1.84477,"twenty":-5.119177,"median":-2.925094,"eighty":-1.258625,"marketCap":226601581},{"date":"2022-04-01","current":1.839041,"twenty":-5.111995,"median":-2.921098,"eighty":-1.243249,"marketCap":225897850},{"date":"2022-04-08","current":1.84477,"twenty":-5.109866,"median":-2.912066,"eighty":-1.232556,"marketCap":226601581},{"date":"2022-04-14","current":1.839041,"twenty":-5.109866,"median":-2.9084,"eighty":-1.221179,"marketCap":225897850},{"date":"2022-04-22","current":1.678626,"twenty":-5.101517,"median":-2.906819,"eighty":-1.206466,"marketCap":206193364},{"date":"2022-04-29","current":1.576492,"twenty":-5.065399,"median":-2.89584,"eighty":-1.184396,"marketCap":193647698},{"date":"2022-05-06","current":1.616621,"twenty":-5.047102,"median":-2.887777,"eighty":-1.175569,"marketCap":198576912},{"date":"2022-05-13","current":-2.225927,"twenty":-5.037348,"median":-2.864933,"eighty":-1.162383,"marketCap":154213985},{"date":"2022-05-20","current":-2.093795,"twenty":-4.983879,"median":-2.845525,"eighty":-1.162383,"marketCap":145059730},{"date":"2022-05-27","current":-1.768545,"twenty":-4.919065,"median":-2.819883,"eighty":-1.162383,"marketCap":122526180},{"date":"2022-06-03","current":-1.971826,"twenty":-4.887514,"median":-2.784964,"eighty":-1.162383,"marketCap":136609649},{"date":"2022-06-10","current":-1.921006,"twenty":-4.809515,"median":-2.763071,"eighty":-1.162383,"marketCap":133088782},{"date":"2022-06-17","current":-1.88035,"twenty":-4.77192,"median":-2.737656,"eighty":-1.162383,"marketCap":130272088},{"date":"2022-06-24","current":-1.941334,"twenty":-4.750077,"median":-2.69655,"eighty":-1.155083,"marketCap":134497128},{"date":"2022-07-01","current":-2.225927,"twenty":-4.72015,"median":-2.663476,"eighty":-1.155083,"marketCap":154213985},{"date":"2022-07-08","current":-2.225927,"twenty":-4.69795,"median":-2.645541,"eighty":-1.155083,"marketCap":154213985},{"date":"2022-07-15","current":-2.053139,"twenty":-4.655198,"median":-2.611624,"eighty":-1.155083,"marketCap":142243036},{"date":"2022-07-22","current":-2.053139,"twenty":-4.595454,"median":-2.596681,"eighty":-1.155083,"marketCap":142243036},{"date":"2022-07-29","current":-2.083631,"twenty":-4.577995,"median":-2.560818,"eighty":-1.155083,"marketCap":144355557},{"date":"2022-08-05","current":-2.236091,"twenty":-4.554159,"median":-2.529885,"eighty":-1.155083,"marketCap":154918159},{"date":"2022-08-12","current":-2.327289,"twenty":-4.532906,"median":-2.496487,"eighty":-1.155083,"marketCap":158443623},{"date":"2022-08-19","current":-2.223854,"twenty":-4.49667,"median":-2.463089,"eighty":-1.155083,"marketCap":151401684},{"date":"2022-08-26","current":-2.21351,"twenty":-4.464109,"median":-2.425085,"eighty":-1.155083,"marketCap":150697490},{"date":"2022-09-02","current":-2.068701,"twenty":-4.439768,"median":-2.385594,"eighty":-1.155083,"marketCap":140838776},{"date":"2022-09-09","current":-2.254885,"twenty":-4.395685,"median":-2.354546,"eighty":-1.155083,"marketCap":153514265},{"date":"2022-09-16","current":-2.151449,"twenty":-4.354193,"median":-2.340271,"eighty":-1.155083,"marketCap":146472327},{"date":"2022-09-23","current":-1.913549,"twenty":-4.315381,"median":-2.327289,"eighty":-1.155083,"marketCap":130275867},{"date":"2022-09-30","current":-1.903205,"twenty":-4.284546,"median":-2.296259,"eighty":-1.155083,"marketCap":129571673},{"date":"2022-10-07","current":-1.79977,"twenty":-4.196575,"median":-2.284356,"eighty":-1.155083,"marketCap":122529735},{"date":"2022-10-14","current":-1.613587,"twenty":-4.003919,"median":-2.265784,"eighty":-1.155083,"marketCap":109854245},{"date":"2022-10-21","current":-1.665305,"twenty":-3.889348,"median":-2.25642,"eighty":-1.155083,"marketCap":113375214},{"date":"2022-10-28","current":-1.685992,"twenty":-3.823683,"median":-2.246256,"eighty":-1.155083,"marketCap":114783602},{"date":"2022-11-04","current":-1.572213,"twenty":-3.797174,"median":-2.237654,"eighty":-1.155083,"marketCap":107037469},{"date":"2022-11-11","current":-1.642004,"twenty":-3.718531,"median":-2.236091,"eighty":-1.155083,"marketCap":112747016},{"date":"2022-11-18","current":-1.703579,"twenty":-3.687034,"median":-2.223854,"eighty":-1.155083,"marketCap":116975029},{"date":"2022-11-25","current":-1.847254,"twenty":-3.665867,"median":-2.219354,"eighty":-1.155083,"marketCap":126840393},{"date":"2022-12-02","current":-1.898567,"twenty":-3.644592,"median":-2.196138,"eighty":-1.155083,"marketCap":130363737},{"date":"2022-12-09","current":-1.867779,"twenty":-3.574214,"median":-2.187557,"eighty":-1.155083,"marketCap":128249730},{"date":"2022-12-16","current":-1.785679,"twenty":-3.528054,"median":-2.179208,"eighty":-1.155083,"marketCap":122612379},{"date":"2022-12-23","current":-1.744629,"twenty":-3.510793,"median":-2.162221,"eighty":-1.155083,"marketCap":119793704},{"date":"2022-12-30","current":-1.908829,"twenty":-3.501328,"median":-2.154159,"eighty":-1.155083,"marketCap":131068406},{"date":"2023-01-06","current":-1.929354,"twenty":-3.496465,"median":-2.151449,"eighty":-1.155083,"marketCap":132477743},{"date":"2023-01-13","current":-2.442481,"twenty":-3.485292,"median":-2.145066,"eighty":-1.155083,"marketCap":167711186},{"date":"2023-01-20","current":-2.36038,"twenty":-3.476513,"median":-2.145066,"eighty":-1.155083,"marketCap":162073835},{"date":"2023-01-27","current":-2.596418,"twenty":-3.465698,"median":-2.145066,"eighty":-1.155083,"marketCap":178281219},{"date":"2023-02-03","current":-2.493793,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":171234530},{"date":"2023-02-10","current":-2.545106,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":174757874},{"date":"2023-02-17","current":-2.575893,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":176871881},{"date":"2023-02-24","current":-2.514318,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":172643868},{"date":"2023-03-03","current":-2.442481,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":167711186},{"date":"2023-03-10","current":-2.052505,"twenty":-3.464548,"median":-2.145066,"eighty":-1.155083,"marketCap":140933770},{"date":"2023-03-17","current":-2.940994,"twenty":-3.451027,"median":-2.145066,"eighty":-1.155083,"marketCap":159310812},{"date":"2023-03-24","current":-3.409471,"twenty":-3.451027,"median":-2.145066,"eighty":-1.155083,"marketCap":184687756},{"date":"2023-03-31","current":-3.357418,"twenty":-3.472861,"median":-2.145066,"eighty":-1.162383,"marketCap":181868095},{"date":"2023-04-06","current":-3.344405,"twenty":-3.473167,"median":-2.145066,"eighty":-1.162383,"marketCap":181163180},{"date":"2023-04-14","current":-4.021094,"twenty":-3.477757,"median":-2.145066,"eighty":-1.155083,"marketCap":217818765},{"date":"2023-04-21","current":-3.969041,"twenty":-3.477757,"median":-2.145066,"eighty":-1.155083,"marketCap":214999105},{"date":"2023-04-28","current":-4.699771,"twenty":-3.477757,"median":-2.145066,"eighty":-1.155083,"marketCap":254582037},{"date":"2023-05-05","current":-4.751846,"twenty":-3.481817,"median":-2.145066,"eighty":-1.155083,"marketCap":257402891},{"date":"2023-05-12","current":-4.841579,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":248940330},{"date":"2023-05-19","current":-4.74557,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":244003836},{"date":"2023-05-26","current":-4.649561,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":239067342},{"date":"2023-06-02","current":-5.074742,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":260928958},{"date":"2023-06-09","current":-4.814148,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":247529903},{"date":"2023-06-16","current":-4.910156,"twenty":-3.486061,"median":-2.145066,"eighty":-1.155083,"marketCap":252466397},{"date":"2023-06-23","current":-5.129605,"twenty":-3.482878,"median":-2.144966,"eighty":-1.147784,"marketCap":263749811},{"date":"2023-06-30","current":-4.553553,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":234130848},{"date":"2023-07-07","current":-4.731854,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":243298623},{"date":"2023-07-14","current":-4.676992,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":240477769},{"date":"2023-07-21","current":-4.827863,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":248235116},{"date":"2023-07-28","current":-4.766143,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":245061656},{"date":"2023-08-04","current":-4.553553,"twenty":-3.479059,"median":-2.144867,"eighty":-1.140484,"marketCap":234130848},{"date":"2023-08-11","current":-5.047451,"twenty":-3.499573,"median":-2.144867,"eighty":-1.140484,"marketCap":248521831},{"date":"2023-08-18","current":-5.448953,"twenty":-3.501743,"median":-2.144867,"eighty":-1.140484,"marketCap":268290613},{"date":"2023-08-25","current":-5.463292,"twenty":-3.517843,"median":-2.144867,"eighty":-1.140484,"marketCap":268996641},{"date":"2023-09-01","current":-4.825191,"twenty":-3.556813,"median":-2.144867,"eighty":-1.140484,"marketCap":237578398},{"date":"2023-09-08","current":-5.133487,"twenty":-3.640374,"median":-2.144867,"eighty":-1.140484,"marketCap":252757998},{"date":"2023-09-15","current":-5.50631,"twenty":-3.703758,"median":-2.144867,"eighty":-1.140484,"marketCap":271114725},{"date":"2023-09-22","current":-5.176505,"twenty":-3.826088,"median":-2.144867,"eighty":-1.140484,"marketCap":254876082},{"date":"2023-09-29","current":-5.405935,"twenty":-3.968328,"median":-2.144867,"eighty":-1.140484,"marketCap":266172529},{"date":"2023-10-06","current":-5.119148,"twenty":-4.056089,"median":-2.144867,"eighty":-1.140484,"marketCap":252051971},{"date":"2023-10-13","current":-5.162166,"twenty":-4.177514,"median":-2.144867,"eighty":-1.140484,"marketCap":254170054},{"date":"2023-10-20","current":-5.07613,"twenty":-4.274571,"median":-2.144867,"eighty":-1.140484,"marketCap":249933887},{"date":"2023-10-27","current":-4.918397,"twenty":-4.28993,"median":-2.139283,"eighty":-1.0445,"marketCap":242167579},{"date":"2023-11-03","current":-5.06179,"twenty":-4.337304,"median":-2.139283,"eighty":-1.0445,"marketCap":249227859},{"date":"2023-11-10","current":-4.617672,"twenty":-4.387475,"median":-2.139283,"eighty":-1.0445,"marketCap":224057346},{"date":"2023-11-17","current":-4.76334,"twenty":-4.445819,"median":-2.139283,"eighty":-1.0445,"marketCap":231125401},{"date":"2023-11-24","current":-4.85074,"twenty":-4.464982,"median":-2.145438,"eighty":-1.0445,"marketCap":235366234},{"date":"2023-12-01","current":-4.333619,"twenty":-4.472069,"median":-2.15395,"eighty":-1.0445,"marketCap":210274639},{"date":"2023-12-08","current":-4.967275,"twenty":-4.532458,"median":-2.162221,"eighty":-1.088842,"marketCap":241020678},{"date":"2023-12-15","current":-4.952708,"twenty":-4.558877,"median":-2.179208,"eighty":-1.088842,"marketCap":240313873},{"date":"2023-12-22","current":-5.083809,"twenty":-4.606027,"median":-2.187557,"eighty":-1.088842,"marketCap":246675122},{"date":"2023-12-29","current":-4.872591,"twenty":-4.625922,"median":-2.195435,"eighty":-1.0445,"marketCap":236426443},{"date":"2024-01-05","current":-4.603105,"twenty":-4.642381,"median":-2.204256,"eighty":-1.000158,"marketCap":223350541},{"date":"2024-01-12","current":-4.559405,"twenty":-4.648459,"median":-2.219354,"eighty":-1.000158,"marketCap":221230124},{"date":"2024-01-19","current":-4.573971,"twenty":-4.64901,"median":-2.225927,"eighty":-0.955816,"marketCap":221936930},{"date":"2024-01-26","current":-5.244044,"twenty":-4.655235,"median":-2.236091,"eighty":-1.000158,"marketCap":254449983},{"date":"2024-02-02","current":-5.637347,"twenty":-4.663277,"median":-2.244541,"eighty":-1.000158,"marketCap":273533732},{"date":"2024-02-09","current":-5.462545,"twenty":-4.676992,"median":-2.254885,"eighty":-1.000158,"marketCap":265052066},{"date":"2024-02-16","current":-5.302311,"twenty":-4.698612,"median":-2.265228,"eighty":-1.014758,"marketCap":257277205},{"date":"2024-02-23","current":-5.360578,"twenty":-4.704812,"median":-2.275572,"eighty":-1.172626,"marketCap":260104427},{"date":"2024-03-01","current":-4.952708,"twenty":-4.730126,"median":-2.294047,"eighty":-1.174097,"marketCap":240313873},{"date":"2024-03-08","current":-4.617672,"twenty":-4.731854,"median":-2.30861,"eighty":-1.174097,"marketCap":224057346},{"date":"2024-03-15","current":-3.715246,"twenty":-4.731854,"median":-2.33774,"eighty":-1.174097,"marketCap":194452106},{"date":"2024-03-22","current":-4.120546,"twenty":-4.731854,"median":-2.344029,"eighty":-1.174097,"marketCap":215665063},{"date":"2024-03-28","current":-4.120546,"twenty":-4.731854,"median":-2.357463,"eighty":-1.174097,"marketCap":215665063},{"date":"2024-04-05","current":-4.120546,"twenty":-4.731854,"median":-2.40143,"eighty":-1.172626,"marketCap":215665063},{"date":"2024-04-12","current":-4.417765,"twenty":-4.731854,"median":-2.423645,"eighty":-1.172626,"marketCap":231221232},{"date":"2024-04-19","current":-4.336705,"twenty":-4.731854,"median":-2.442481,"eighty":-1.172626,"marketCap":226978640},{"date":"2024-04-26","current":-4.045244,"twenty":-4.731854,"median":-2.459275,"eighty":-1.174097,"marketCap":211723876},{"date":"2024-05-03","current":-4.153478,"twenty":-4.731854,"median":-2.463048,"eighty":-1.174097,"marketCap":217388729},{"date":"2024-05-10","current":-4.12642,"twenty":-4.731854,"median":-2.477117,"eighty":-1.174097,"marketCap":215972516},{"date":"2024-05-17","current":-4.584799,"twenty":-4.731854,"median":-2.500272,"eighty":-1.174097,"marketCap":232343653},{"date":"2024-05-24","current":-4.213815,"twenty":-4.731854,"median":-2.517501,"eighty":-1.174097,"marketCap":213543327},{"date":"2024-05-31","current":-4.283812,"twenty":-4.731854,"median":-2.532364,"eighty":-1.17704,"marketCap":217090558},{"date":"2024-06-07","current":-4.339809,"twenty":-4.731854,"median":-2.554718,"eighty":-1.194696,"marketCap":219928343},{"date":"2024-06-14","current":-4.479803,"twenty":-4.731854,"median":-2.565631,"eighty":-1.262647,"marketCap":227022806},{"date":"2024-06-21","current":-0.981357,"twenty":-4.731854,"median":-2.565631,"eighty":-1.005688,"marketCap":49732183},{"date":"2024-06-28","current":-1.016915,"twenty":-4.731854,"median":-2.575893,"eighty":-0.000614,"marketCap":51534177},{"date":"2024-07-05","current":-1.052334,"twenty":-4.731854,"median":-2.575893,"eighty":-0.000614,"marketCap":53329076},{"date":"2024-07-12","current":-1.328542,"twenty":-4.731854,"median":-2.575893,"eighty":-0.000614,"marketCap":67326451},{"date":"2024-07-15","current":-1.334701,"twenty":-4.731854,"median":-2.575893,"eighty":-0.000614,"marketCap":67638607},{"date":"2024-08-02","current":-1.385799,"twenty":-4.734206,"median":-2.596418,"eighty":1.509344,"marketCap":70228086},{"date":"2024-08-09","current":-1.280944,"twenty":-4.734206,"median":-2.596418,"eighty":1.509344,"marketCap":64914333},{"date":"2024-08-16","current":-2.695912,"twenty":-4.734206,"median":-2.59655,"eighty":1.509344,"marketCap":80197882},{"date":"2024-08-23","current":-2.886773,"twenty":-4.734206,"median":-2.613367,"eighty":1.509344,"marketCap":85875608},{"date":"2024-08-30","current":-2.862915,"twenty":-4.734206,"median":-2.650334,"eighty":1.509344,"marketCap":85165892},{"date":"2024-09-06","current":-2.71977,"twenty":-4.734206,"median":-2.661824,"eighty":1.509344,"marketCap":80907597},{"date":"2024-09-13","current":-2.648197,"twenty":-4.734206,"median":-2.667765,"eighty":1.509344,"marketCap":78778450},{"date":"2024-09-20","current":-2.791343,"twenty":-4.734206,"median":-2.695912,"eighty":1.509344,"marketCap":83036745},{"date":"2024-09-27","current":-2.672054,"twenty":-4.734206,"median":-2.695912,"eighty":1.509344,"marketCap":79488166},{"date":"2024-10-04","current":-2.695912,"twenty":-4.734206,"median":-2.696483,"eighty":1.509344,"marketCap":80197882},{"date":"2024-10-11","current":-2.600482,"twenty":-4.734206,"median":-2.701653,"eighty":1.509344,"marketCap":77359018},{"date":"2024-10-18","current":-2.791343,"twenty":-4.734206,"median":-2.71977,"eighty":1.509344,"marketCap":83036745},{"date":"2024-10-25","current":-2.886773,"twenty":-4.734206,"median":-2.743627,"eighty":1.509344,"marketCap":85875608},{"date":"2024-10-31","current":-2.743627,"twenty":-4.734206,"median":-2.77273,"eighty":1.509344,"marketCap":81617313},{"date":"2024-11-08","current":-3.101492,"twenty":-4.734206,"median":-2.791343,"eighty":1.510454,"marketCap":92263050},{"date":"2024-11-15","current":-2.512505,"twenty":-4.734206,"median":-2.797849,"eighty":1.510454,"marketCap":81661345},{"date":"2024-11-22","current":-2.315874,"twenty":-4.734206,"median":-2.797849,"eighty":1.510454,"marketCap":75270457},{"date":"2024-11-29","current":-2.490657,"twenty":-4.734206,"median":-2.791343,"eighty":1.510454,"marketCap":80951247},{"date":"2024-12-06","current":-2.250331,"twenty":-4.734206,"median":-2.78121,"eighty":1.510454,"marketCap":73140161},{"date":"2024-12-13","current":-2.315874,"twenty":-4.734206,"median":-2.743627,"eighty":1.510454,"marketCap":75270457},{"date":"2024-12-20","current":-2.228483,"twenty":-4.734206,"median":-2.71977,"eighty":1.510454,"marketCap":72430063},{"date":"2024-12-27","current":-2.180636,"twenty":-4.734206,"median":-2.719769,"eighty":1.510454,"marketCap":70874947},{"date":"2025-01-03","current":-2.093026,"twenty":-4.734206,"median":-2.696417,"eighty":1.510454,"marketCap":68027451},{"date":"2025-01-10","current":-1.987938,"twenty":-4.734206,"median":-2.695912,"eighty":1.511564,"marketCap":64611877},{"date":"2025-01-17","current":-1.594895,"twenty":-4.734206,"median":-2.672054,"eighty":1.511564,"marketCap":51837202},{"date":"2025-01-24","current":-1.550762,"twenty":-4.734206,"median":-2.668747,"eighty":1.511564,"marketCap":50402802},{"date":"2025-01-31","current":-1.52957,"twenty":-4.734206,"median":-2.648197,"eighty":1.511564,"marketCap":49714007},{"date":"2025-02-07","current":-1.522797,"twenty":-4.734206,"median":-2.615387,"eighty":1.511564,"marketCap":49493876},{"date":"2025-02-14","current":-1.410717,"twenty":-4.734206,"median":-2.603272,"eighty":1.511564,"marketCap":45851070},{"date":"2025-02-21","current":-1.238774,"twenty":-4.734206,"median":-2.59655,"eighty":1.511564,"marketCap":40262594},{"date":"2025-02-28","current":-1.160777,"twenty":-4.734206,"median":-2.583439,"eighty":1.511564,"marketCap":37727541},{"date":"2025-03-07","current":-1.133031,"twenty":-4.734206,"median":-2.565631,"eighty":1.512673,"marketCap":36825716},{"date":"2025-03-14","current":-1.183105,"twenty":-4.734206,"median":-2.565631,"eighty":1.512673,"marketCap":31273002},{"date":"2025-03-21","current":-1.157829,"twenty":-4.734206,"median":-2.565631,"eighty":1.512673,"marketCap":30604897},{"date":"2025-03-28","current":-1.018814,"twenty":-4.734206,"median":-2.560818,"eighty":1.512673,"marketCap":26930319},{"date":"2025-04-04","current":-0.810427,"twenty":-4.734206,"median":-2.552766,"eighty":1.512673,"marketCap":21422006},{"date":"2025-04-11","current":-0.685663,"twenty":-4.734206,"median":-2.539975,"eighty":1.511564,"marketCap":18124126},{"date":"2025-04-17","current":-0.728416,"twenty":-4.734206,"median":-2.517501,"eighty":1.511564,"marketCap":19254218},{"date":"2025-04-25","current":-0.905613,"twenty":-4.734206,"median":-2.504056,"eighty":1.512673,"marketCap":23938061},{"date":"2025-05-02","current":-0.847533,"twenty":-4.734206,"median":-2.490657,"eighty":1.512673,"marketCap":22402841},{"date":"2025-05-09","current":-0.790529,"twenty":-4.734206,"median":-2.471439,"eighty":1.512673,"marketCap":20896051},{"date":"2025-05-16","current":-0.869293,"twenty":-4.734206,"median":-2.463006,"eighty":1.512673,"marketCap":21709734},{"date":"2025-05-23","current":-0.816333,"twenty":-4.733318,"median":-2.442481,"eighty":1.512673,"marketCap":20387097},{"date":"2025-05-30","current":-0.856765,"twenty":-4.731933,"median":-2.432218,"eighty":1.512673,"marketCap":21396852},{"date":"2025-06-06","current":-0.892072,"twenty":-4.731933,"median":-2.40143,"eighty":1.512673,"marketCap":22278610},{"date":"2025-06-13","current":-0.823736,"twenty":-4.731933,"median":-2.354546,"eighty":1.512673,"marketCap":20571982},{"date":"2025-06-20","current":-0.842528,"twenty":-4.731854,"median":-2.337847,"eighty":1.513783,"marketCap":21041305},{"date":"2025-06-27","current":-0.976638,"twenty":-4.729263,"median":-2.323309,"eighty":1.513783,"marketCap":24390563},{"date":"2025-07-03","current":-0.96354,"twenty":-4.704942,"median":-2.315874,"eighty":1.513783,"marketCap":24063459},{"date":"2025-07-11","current":-1.193036,"twenty":-4.688524,"median":-2.2961,"eighty":1.513783,"marketCap":29794886},{"date":"2025-07-18","current":-1.364731,"twenty":-4.672427,"median":-2.280743,"eighty":1.513783,"marketCap":34082790},{"date":"2025-07-25","current":-1.973208,"twenty":-4.662896,"median":-2.265228,"eighty":1.513783,"marketCap":49278893},{"date":"2025-08-01","current":-1.423671,"twenty":-4.649561,"median":-2.254885,"eighty":1.513783,"marketCap":35554757},{"date":"2025-08-08","current":-1.456415,"twenty":-4.621238,"median":-2.246129,"eighty":1.513783,"marketCap":36372516},{"date":"2025-08-15","current":-1.565125,"twenty":-4.604965,"median":-2.237654,"eighty":1.513783,"marketCap":59753324},{"date":"2025-08-22","current":-1.782487,"twenty":-4.582633,"median":-2.232287,"eighty":1.513783,"marketCap":68051804},{"date":"2025-08-29","current":-2.328223,"twenty":-4.559405,"median":-2.225927,"eighty":1.513783,"marketCap":88886892},{"date":"2025-09-05","current":-2.402726,"twenty":-4.553553,"median":-2.225927,"eighty":1.514893,"marketCap":91731273},{"date":"2025-09-12","current":-2.328223,"twenty":-4.521194,"median":-2.225927,"eighty":1.513783,"marketCap":88886892},{"date":"2025-09-19","current":-2.272346,"twenty":-4.49687,"median":-2.22489,"eighty":1.513783,"marketCap":86753607},{"date":"2025-09-26","current":-2.626235,"twenty":-4.464109,"median":-2.22489,"eighty":1.513783,"marketCap":100264414},{"date":"2025-10-03","current":-3.054628,"twenty":-4.434888,"median":-2.22489,"eighty":1.513783,"marketCap":116619602},{"date":"2025-10-10","current":-3.240886,"twenty":-4.407006,"median":-2.22489,"eighty":1.513783,"marketCap":123730554},{"date":"2025-10-17","current":-2.924248,"twenty":-4.361742,"median":-2.22489,"eighty":1.513783,"marketCap":111641936},{"date":"2025-10-24","current":-2.905622,"twenty":-4.339188,"median":-2.22489,"eighty":1.513783,"marketCap":110930841},{"date":"2025-10-31","current":-2.551732,"twenty":-4.331369,"median":-2.22489,"eighty":1.513783,"marketCap":97420034},{"date":"2025-11-07","current":-2.477229,"twenty":-4.323195,"median":-2.22489,"eighty":1.513783,"marketCap":94575653},{"date":"2025-11-14","current":-2.235094,"twenty":-4.323001,"median":-2.22489,"eighty":1.513783,"marketCap":85331416},{"date":"2025-11-21","current":-2.391386,"twenty":-4.283583,"median":-2.22489,"eighty":1.513783,"marketCap":86879070},{"date":"2025-11-28","current":-3.489072,"twenty":-4.250079,"median":-2.22489,"eighty":1.513783,"marketCap":126757988},{"date":"2025-12-05","current":-3.175448,"twenty":-4.218628,"median":-2.22489,"eighty":1.513783,"marketCap":115364011},{"date":"2025-12-12","current":-3.234252,"twenty":-4.218628,"median":-2.235593,"eighty":1.513783,"marketCap":117500382},{"date":"2025-12-19","current":-2.626605,"twenty":-4.218628,"median":-2.236091,"eighty":1.513783,"marketCap":95424553}],"updateTime":1766476583668},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OVID\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592187719","title":"Ra Capital Management, L.p. Reports 9.9% Passive Stake in Ovid Therapeutics as of Dec 11 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2592187719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592187719?lang=en_us&edition=fundamental","pubTime":"2025-12-19 07:11","pubTimestamp":1766099497,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO166:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OVID","BK4139"],"gpt_icon":0},{"id":"2592909951","title":"BRIEF-Ovid Therapeutics Announces Phase 1 Results For Ov350","url":"https://stock-news.laohu8.com/highlight/detail?id=2592909951","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592909951?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:33","pubTimestamp":1766064817,"startTime":"0","endTime":"0","summary":"BRIEF-Ovid Therapeutics Announces Phase 1 Results For Ov350Dec 18 (Reuters) - Ovid Therapeutics Inc OVID.O:OVID THERAPEUTICS INC - ANNOUNCES PHASE 1 RESULTS FOR OV350OVID THERAPEUTICS INC - OV350 SHOW","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0PX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"2592906064","title":"Ovid Therapeutics Showcases Neurotherapeutics Pipeline Targeting Neural Hyperexcitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906064","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906064?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:19","pubTimestamp":1766063980,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc. has provided an update on its neurotherapeutics pipeline, highlighting several clinical-stage programs targeting conditions driven by neural hyperexcitability. The company is advancing OV329, a GABA-aminotransferase inhibitor, for drug-resistant adult focal onset seizures. Phase 1 results showed a strong safety profile, positive biomarker outcomes, and inhibitory effects comparable to or exceeding those of vigabatrin. The next phase for OV329 includes a Phase 2a trial, with topline results expected in mid-2027. Ovid is also developing oral formulations in its potassium-chloride cotransporter 2  direct activator portfolio. OV4071 is being prepared for indications such as psychosis associated with Parkinson's disease, Lewy body dementia, and schizophrenia, with regulatory submissions and a proof-of-mechanism study planned. Another candidate, OV4041, is targeting generalized anxiety disorder and Rett syndrome, with late-stage preclinical development underway. The co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL14kprY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","BK4139"],"gpt_icon":0},{"id":"2592906996","title":"Ovid Therapeutics Inc - Ov350 Shows Good Safety Profile Supporting Kcc2 Portfolio Advancement","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906996","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906996?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:06","pubTimestamp":1766063213,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0PX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"2592906957","title":"Ovid Therapeutics Inc - Announces Phase 1 Results for Ov350","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906957?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:06","pubTimestamp":1766063213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0PX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OVID","BK4139"],"gpt_icon":0},{"id":"2592590699","title":"Ovid Therapeutics Inc - No Treatment-Related Safety Findings or Serious Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2592590699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592590699?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:06","pubTimestamp":1766063213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0PX:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"2592906847","title":"Ovid Therapeutics Announces Phase 1/1b Clinical Trial Submission for Oral KCC2 Activator OV4071","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906847","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906847?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:00","pubTimestamp":1766062830,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc. announced results from its Phase 1 study of OV350, the first KCC2 direct activator dosed in humans. The study met its primary objectives, demonstrating safety, tolerability, and pharmacokinetics of OV350. The results from this study will be submitted for presentation at a future congress. Ovid also reported that it will not advance OV350 IV further in the clinic, instead prioritizing the development of its oral KCC2 direct activator programs, including OV4071 and OV4041. The company plans to submit a regulatory application for a Phase 1/1b clinical trial of OV4071 in the first quarter of 2026, with initiation of clinical studies expected in the second quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL75n40h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2210149790.SGD","LU2210150020.SGD","SG9999014005.SGD","BK4588","OVID","IE00B3QW5Z07.USD","LU0314104364.USD","LU2095319765.USD","SG9999014013.SGD","BK4585","SG9999014021.USD","BK4139","SG9999014039.USD","IE00B64PRP62.GBP","NDAQ","BK4112","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2590545106","title":"Ovid Therapeutics Inc. Held Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2590545106","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590545106?lang=en_us&edition=fundamental","pubTime":"2025-12-12 02:59","pubTimestamp":1765479550,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc. held a special meeting of stockholders on December 11, 2025. Stockholders approved an increase in authorized shares of common stock from 125,000,000 to 315,000,000. Approval was also granted for the issuance of shares of common stock upon the conversion of Series B Preferred Stock and the exercise of related warrants. In addition, the issuance and sale of preferred stock and warrants to the Chief Executive Officer was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ovid Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 11, 2025, and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDLbHFYCB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","BK4139"],"gpt_icon":0},{"id":"2588303520","title":"Ovid Therapeutics Names Dr. Petra Kaufmann as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2588303520","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588303520?lang=en_us&edition=fundamental","pubTime":"2025-12-02 20:00","pubTimestamp":1764676816,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc. has appointed Dr. Petra Kaufmann as Chief Medical Officer. Dr. Kaufmann will oversee clinical, medical, and regulatory strategy as Ovid advances its pipeline of therapies for brain disorders. She joins Ovid from Vigil Neuroscience and has previously held senior roles at Affinia Therapeutics, Novartis Gene Therapies, and the National Institutes of Health.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ovid Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on December 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL9W3rTL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","LU2210149790.SGD","BK4588","VIGL","IE00B64PRP62.GBP","LU2210150020.SGD","BK4139","LU0314104364.USD","OVID","IE00B3QW5Z07.USD","LU2095319765.USD","NDAQ","IE00BKPKM429.USD","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2588030829","title":"Ovid Therapeutics Appoints DR. Petra Kaufmann as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2588030829","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588030829?lang=en_us&edition=fundamental","pubTime":"2025-12-02 20:00","pubTimestamp":1764676801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA1WGMW3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OVID","BK4139"],"gpt_icon":0},{"id":"2583704305","title":"Ovid Therapeutics Showcases Neurotherapeutics Pipeline Targeting Drug-Resistant Seizures and Neural Hyperexcitability","url":"https://stock-news.laohu8.com/highlight/detail?id=2583704305","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583704305?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:31","pubTimestamp":1763119884,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc. has provided an update on its neurotherapeutics pipeline targeting conditions driven by neural hyperexcitability. The company highlighted progress on multiple clinical programs, including OV329, a GABA-aminotransferase inhibitor being developed for drug-resistant adult focal onset seizures. Phase 1 results for OV329 demonstrated a strong safety profile and pharmacodynamic activity, with Phase 2a initiation expected in the second quarter of 2026 and topline results anticipated in mid-2027. Ovid also reported on OV350 IV, a first-in-human direct activator of KCC2, with Phase 1 topline findings expected in the fourth quarter of 2025. Other pipeline candidates include OV4071 for psychosis associated with Parkinson's disease, Lewy body dementia, and schizophrenia, with regulatory submissions and Phase 1 studies planned for 2026, and OV4041 targeting generalized anxiety disorder and Rett syndrome, moving toward IND submission in late 2026. The company stated it has an ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL7pYrkB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"2583706965","title":"BTIG Keeps Their Buy Rating on Ovid Therapeutics (OVID)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583706965","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583706965?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:17","pubTimestamp":1763119037,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Thomas Shrader from BTIG maintained a Buy rating on Ovid Therapeutics, with a price target of $4.00. The company’s ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-keeps-their-buy-rating-on-ovid-therapeutics-ovid-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-keeps-their-buy-rating-on-ovid-therapeutics-ovid-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OVID"],"gpt_icon":0},{"id":"2582375669","title":"Ovid Therapeutics Q3 revenue slightly beats expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2582375669","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582375669?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:13","pubTimestamp":1762949618,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Q3 revenue slightly beats expectationsOverviewOvid Therapeutics Q3 revenue slightly beats analyst expectationsMeg Alexander appointed CEO, effective January 2026OutlookOvid plans Pha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO0D6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","BK4139"],"gpt_icon":0},{"id":"2582737583","title":"Ovid Therapeutics reports Q3 revenue of $132,000 and R&D expenses of $5.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582737583","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582737583?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:03","pubTimestamp":1762949005,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc. reported cash, cash equivalents and marketable securities of $25.6 million as of September 30, 2025. This was supplemented by an $81 million private placement in October 2025, with up to an additional $94 million possible from warrants. Revenue from royalty agreements for the third quarter was $0.1 million, compared to $0.2 million in the same period in 2024. Research and development expenses decreased to $5.9 million from $7.9 million, while general and administrative expenses increased to $6.8 million from $5.5 million. Total operating expenses were $12.7 million, down from $13.4 million a year earlier. The net loss for the quarter was $12.2 million, or $0.17 per share, compared to a net loss of $14.0 million, or $0.20 per share, in 2024. Key business developments include the appointment of Meg Alexander as CEO effective January 1, 2026, and advancement of OV329, a next-generation GABA-aminotransferase inhibitor, which showed strong Phase 1 results and will pro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL10fNfq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OVID","BK4139","BK4223","BK4080","BK4194","BK4231","BK4585","VNO","ALX","BK4588"],"gpt_icon":0},{"id":"2582373183","title":"BRIEF-Ovid Therapeutics Q3 EPS USD -0.17","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373183","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373183?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948847,"startTime":"0","endTime":"0","summary":"BRIEF-Ovid Therapeutics Q3 EPS USD -0.17\n\n\nNov 12 (Reuters) - Ovid Therapeutics Q3 revenue USD 132 thousand vs. IBES estimate USD 153.3 thousand.\n\nQ3 net income USD -12.158 million\nQ3 operating expenses USD 12.655 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX366B4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"2582037315","title":"Ovid Therapeutics Names Meg Alexander as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2582037315","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582037315?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948845,"startTime":"0","endTime":"0","summary":"Ovid Therapeutics Inc. announced that Meg Alexander will become Chief Executive Officer and join the Board of Directors effective January 1, 2026. Dr. Jeremy M. Levin, the current Chairman and CEO, will transition to the role of Executive Chairman of the Board.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ovid Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on November 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL3WD5sS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4080","BK4194","BK4585","BK4231","LU2095319765.USD","BK4139","LU2210149790.SGD","LU0314104364.USD","OVID","VNO","BK4223","IE00BKPKM429.USD","BK4588","LU2210150020.SGD","NDAQ","BK4112","IE00B64PRP62.GBP","ALX","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2582373985","title":"Ovid Therapeutics Q3 Revenue USD 132 Thousand VS. Ibes Estimate USD 153.3 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373985?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX366B4C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OVID","BK4139"],"gpt_icon":0},{"id":"2582373281","title":"Ovid Therapeutics Inc - Jeremy M. Levin to Transition to Executive Chair of Bod","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373281","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373281?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX366B4C:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"2582137393","title":"Ovid Therapeutics Inc - Meg Alexander Appointed CEO Effective January 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2582137393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582137393?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLX366B4C:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OVID"],"gpt_icon":0},{"id":"2582373250","title":"Press Release: Ovid Therapeutics Announces Planned Leadership Succession and Reports Business Updates and Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373250","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373250?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:00","pubTimestamp":1762948800,"startTime":"0","endTime":"0","summary":"-- Meg Alexander appointed Chief Executive Officer effective January 1,2026; Dr. Jeremy M. Levin to transition to Executive Chair of the Board. demonstrated strong inhibitory activity and a potential best-in-category. safety profile in a Phase 1 study, supporting advancement into planned. -- OV329 Phase 1 results selected for late-breaking poster presentation at. \"Ovid is operating from a position of scientific and fiscal strength. The OV329 biomarker results, progress across our KCC2 direct activator programs, and our recent financing reflect disciplined execution,\" said Dr. Jeremy M. Levin, D.Phil., MB BChir. \"Over the past four years, Meg and I have worked closely with our team to build this foundation. She has led key facets of the business, including development of our pipeline and scientific strategy. I have deep respect for Meg's judgment, integrity and strong leadership, and the Board and I have full confidence in her. I look forward to supporting a smooth handover while strate","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4519","IE00B19Z3581.USD","BK4588","BK4539","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","BK4139","LU0061475181.USD","LU1093756168.USD","GABA","CEO","IE0002270589.USD","BK4007","BK4211","LU1093756325.SGD","LENZ","BK4105","OVID","BK4585","AES"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}]}}